Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?
Objective(s): Brucellosis is a common infectious disease among animals and humans. While subunit vaccines could be used as an efficient strategy against pathogens, they usually seem to be less immunogenic than live or killed vaccines. However, the use of a suitable adjuvant accompanied by subunit va...
Main Authors: | Soheil Yousefi, Tooba Abbassi-Daloii, Mojtaba Tahmoorespour, Mohammad Hadi Sekhavati |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2019-04-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | http://ijbms.mums.ac.ir/article_12315_f8f05fba4cd47bb3764fa4b2a83c0e92.pdf |
Similar Items
-
Evaluation of the immunogenicity and efficacy of a chimeric OMP25–OMP31 antigen in BALB/c mice
by: Yahya Mohammadi
Published: (2021-09-01) -
Cloning, expression and molecular analysis of Iranian Brucella melitensis Omp25 gene for designing a subunit vaccine
by: Soheil Yousefi, et al.
Published: (2016-01-01) -
In silico analysis of Omp25 and BLS Brucella melitensis antigens for designing subunit vaccine
by: Tahmoorespur, M., et al.
Published: (2016-03-01) -
Preparation and Evaluation of Immunogenicity of Chitosan Nanoparticles Containing Tetanotoxin in Comparison with Freund\'s Adjuvant in Mouse Model for Improvement of Tetanus Vaccine after Subcutaneous Injection
by: Majdedin Ghalavand, et al.
Published: (2017-04-01) -
The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide
by: Oriana eMayorga, et al.
Published: (2012-05-01)